Connor, Clark & Lunn Investment Management (CC&L)
FPRX

Connor, Clark & Lunn Investment Management (CC&L)’s Five Prime Therapeutics, Inc. FPRX Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio FPRX Stock Details FPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-13,906
Closed -$85K – 1196
2020
Q2 		$85K Sell
13,906
-4,209
-23% -$17.3K ﹤0.01% 963
2020
Q1 		$41K Sell
18,115
-2,425
-12% -$10.3K ﹤0.01% 972
2019
Q4 		$94K Buy
+20,540
New +$81.3K ﹤0.01% 881
2018
Q3 		– Sell
-24,625
Closed -$389K – 1151
2018
Q2 		$389K Sell
24,625
-5,750
-19% -$100K ﹤0.01% 823
2018
Q1 		$522K Buy
+30,375
New +$593K ﹤0.01% 562
2017
Q1 		– Sell
-11,600
Closed -$581K – 1047
2016
Q4 		$581K Sell
11,600
-20,750
-64% -$1.09M ﹤0.01% 572
2016
Q3 		$1.7M Sell
32,350
-575
-2% -$27.5K 0.01% 392
2016
Q2 		$1.36M Buy
+32,925
New +$1.43M 0.01% 421

Other funds holding FPRX

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L)'s FPRX Position: Q3 2020 in Review

Connor, Clark & Lunn Investment Management (CC&L) sold out of Five Prime Therapeutics, Inc. (FPRX) in Q3 2020, closing a stake of 13,906 shares — an estimated $85K sold.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in FPRX in Q2 2016 and held it in 8 quarters. The position peaked at $1.7M in Q3 2016. 94 funds tracked by Wall St. Rank hold FPRX as of Q3 2020.

  • Connor, Clark & Lunn Investment Management (CC&L) reported no remaining Five Prime Therapeutics, Inc. position as of Q3 2020 after selling out during the quarter.
  • Connor, Clark & Lunn Investment Management (CC&L) sold 13,906 Five Prime Therapeutics, Inc. shares in Q3 2020, an estimated $85K.
  • Connor, Clark & Lunn Investment Management (CC&L) first reported a position in Five Prime Therapeutics, Inc. in Q2 2016 and held it in 8 quarters.
  • Connor, Clark & Lunn Investment Management (CC&L)'s Five Prime Therapeutics, Inc. position peaked at $1.7M in Q3 2016.
  • 94 funds tracked by Wall St. Rank held Five Prime Therapeutics, Inc. as of Q3 2020.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q3 2020, filed 12 Nov 2020.